Koninklijke Philips NV income statement
In fiscal 2025, Koninklijke Philips NV reported revenue of $20.16bn, up 3.4% on the year before, operating income of $1.61bn (a 8.0% margin) and net income of $1.01bn, or $1.05 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 18.6 | 19.3 | 20.1 | 21.4 | 19.2 | 19.8 | 20.3 | 18.8 | 19.7 | 19.5 | 20.2 |
| Cost of revenue | 10.6 | 10.5 | 10.8 | 11.3 | 10.4 | 10.8 | 11.8 | 11.2 | 11.6 | 11.1 | 11.1 |
| Gross profit | 8.0 | 8.8 | 9.2 | 10.1 | 8.8 | 8.9 | 8.5 | 7.6 | 8.1 | 8.4 | 9.1 |
| Research and development | 1.7 | 1.8 | 2.0 | 2.1 | 2.0 | 2.1 | 2.1 | 2.2 | 2.0 | 1.9 | 1.9 |
| Operating income | 0.7 | 1.6 | 1.7 | 2.0 | 1.5 | 1.4 | 0.7 | −1.6 | −0.1 | 0.6 | 1.6 |
| Interest expense | 0.4 | 0.4 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 |
| Income before tax | 0.4 | 1.1 | 1.6 | 1.8 | 1.4 | 1.4 | 0.6 | −1.8 | −0.6 | 0.1 | 1.3 |
| Income tax | 0.2 | 0.2 | 0.4 | 0.2 | 0.3 | 0.2 | −0.1 | −0.1 | −0.1 | 1.0 | 0.3 |
| Net income | 0.7 | 1.6 | 1.9 | 1.3 | 1.3 | 1.4 | 3.9 | −1.7 | −0.5 | −0.8 | 1.0 |
| Diluted EPS | $0.75 | $1.73 | $1.98 | $1.35 | $1.40 | $1.47 | $4.14 | −$1.78 | −$0.53 | −$0.81 | $1.05 |
| Diluted shares (average) | 916m | 918m | 929m | 941m | 921m | 908m | 944m | 952m | 948m | 933m | 963m |
| EBITDA | 1.8 | 2.7 | 2.9 | 3.3 | 3.0 | 3.1 | 2.2 | 0.1 | 1.2 | 2.1 | 2.9 |
Compare with peers
- Boston Scientific income statement
- GE HealthCare income statement
- Stryker Corporation income statement
- Baxter International income statement
- Intuitive Surgical income statement
Head to head: BSX vs PHGGEHC vs PHGPHG vs SYK
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies